Watson Pharmaceuticals is looking to acquire Actavis, according to published reports.
The Food and Drug Administration has approved Watson's generic version of a drug used to prevent and treat osteoporosis in post-menopausal women, the company said.
Israel-based Teva Pharmaceutical Industries is switching stock exchanges, the company said.
Taro Pharmaceutical Industries will list its shares on the New York Stock Exchange, the Israel-based generic drug maker said Monday.
The Food and Drug Administration has approved the first generic version of a drug for treating and preventing osteoporosis in women after menopause, the agency said Monday.
Women take mental health drugs at a much higher rate than men, according to a new study by one of the country's largest pharmacy benefit managers.
Watson Pharmaceuticals is challenging the patent protection on a drug made by Abbott for treating cholesterol, the company said.
Another generic drug maker has joined efforts to challenge the patent on a drug made by Forest Labs for treating hypertension.
Amneal Pharmaceuticals has launched a generic version of an antidepressant made by Forest Labs.
The Food and Drug Administration has approved the first generic version of an antidepressant made by Forest Labs, the agency said Wednesday.